Vermont S0162 modifies provisions affecting the Department of Vermont Health Access, including changes to drug cost transparency, Medicaid and.
Vermont S0162 makes several changes to provisions affecting the Department of Vermont Health Access. It eliminates the requirement for the Department to create annual lists of prescription drugs with significant price increases and provides those lists to the Office of the Attorney General. The bill also modifies the membership of the Medicaid and Exchange Advisory Committee and eliminates the Commissioner’s ability to reappoint members to that Committee for additional terms.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.